| Here's an interesting statistic: 10% of all condom | | | | commercial product to use Vystar's flagship |
| users who are exposed to the latex protiens | | | | developmental offering. "Vytex is the culmination of |
| in latex that are added to rubber products are | | | | years of research resulting in a very good natural |
| allergic and exposed. These users aren't just allergic | | | | rubber latex product that maintains all of the good |
| to the latex in condoms; there are over 40,000 | | | | properties of latex such as barrier protection and |
| products that require a latex application, everything | | | | elasticity, and yet, we have been able to remove the |
| from automotive tires to apparel, to heavy industrial | | | | proteins that cause some people to have allergies" |
| uses like foam. The allergic properties of latex come | | | | said Mr. Doyle. He went on to talk about market size |
| from the naturally occurring chemicals that make up | | | | and the potential for Vystar's NRL to be included in |
| the latex in its rawest form: as sap from South | | | | every industrial application available. "The potential |
| African and Latin American trees. While there are | | | | market size is huge, just as a raw material. It is a $3 |
| ways to reduce the allergenic properties of latex | | | | billion market selling to the companies who produce |
| during production, they cannot be eliminated. And | | | | gloves, condoms, catheters, etc." |
| that's where Vystar comes in. | | | | Checking into the first quarter's earning reveals a |
| Mr. Doyle gave me a brief history of the demand for | | | | company with almost no debt and increasing strength |
| hypoallergenic, or "reduced" allergenic latex, and how | | | | in cash flow. Total assets are $1.2M versus $336K in |
| hard Vystar has been working to provide a solution. | | | | total liabilities, a quick ratio of about 3.5; a strong |
| During the tremulous years of the late 1980's, the | | | | indication the company could access credit to finance |
| AIDS crisis was gaining recognition and healthcare | | | | growth in the future. Total revenues were $83K for |
| professionals had been required to begin wearing | | | | the first quarter 2010 compared with only $11K for |
| those ubiquitous latex gloves when treating patients, | | | | the same period in 2009, attributable to sales of the |
| leading to a huge explosion of latex glove production | | | | Envy condom. |
| in Southeast Asia, a region not particularly known for | | | | So how's business? |
| its quality production levels. The factories ignored | | | | "We have a solid core of investors in the healthcare |
| standard western safety procedures that involved | | | | arena. We've never taken a loan, we've never |
| how the latex is washed, processed, and dropped | | | | worked with any venture capital groups, and we're |
| into the product, sparking a wave of | | | | doing very well in the financing area". For a company |
| allergy-connected health issues during the 90's and | | | | preparing to tackle such huge market potential, those |
| today. | | | | are the exact qualities others would be Envious for. |
| Mr. Doyle said the issue has been getting better as | | | | To watch a video on the Business News Network |
| production quality improves, but the need for Vytex | | | | that my conversation with Mr. Doyle was based off |
| NRL is obvious. The Envy condom received FDA | | | | of, click here. |
| 501(k) clearance in 2009 and became the first | | | | |